医疗特长：1987年毕业于中山医科，于中山肿瘤防治中心从事肿瘤放疗领域近三十年，是专业临床放射治疗学医生。擅长头颈部肿瘤（包括鼻咽癌、喉癌、下咽癌等）以及前列腺癌等多种恶性肿瘤的诊断、化学治疗和放射治疗为主的肿瘤综合治疗。研究方向：头颈部肿瘤（包括鼻咽癌、喉癌、下咽癌等）以及前列腺癌等多种恶性肿瘤的放化综合治疗。主要教育和工作经历：教育经历:1.1981/09-1987/07，中山医科（临床医学），学士2.1994/09-1997/12，中山医科（肿瘤学），硕士工作经历:1.1987/07-1994/11，中山肿瘤防治中心/放疗科，住院医师2.1994/11-2002/1，中山肿瘤防治中心/放疗科，主治医师3.2002/01-2014/12，中山肿瘤防治中心/放疗科，副主任医师，兼任放疗门诊区长4.2014/12-2017/05，中山肿瘤防治中心/放疗科，主任医师，兼任放疗门诊区长5.2017/05-至今，中山附属医院/放射治疗科，主任医师、科室主任社会兼职：广东省医师协会放射治疗医师分会常委论著（SCI，作者/通信作者）：(1)PotentialsurrogateendpointsforoverallsurvivalinlocoregionallyadvancednasopharyngealcarcinomaanysisofaphaseIIIrandomizedtrial.ScientificReports.(IF=5.578)(2)Developmentandexternalvalidationofnomogramsforpredictingsurvivalinnasopharyngealcarcinomapatientsafterdefinitiveradiotherapy.ScientificReports.(IF=5.578)(3)Progressreportofarandomizedtrialcomparinglong-termsurvivalandlatetoxicityofconcurrentchemoradiotherapywithadjuvantchemotherapyversusradiotherapyaloneinpatientswithstageIIItoIVBnasopharyngealcarcinomafromendemicregionsofChina.Cancer.(IF=4.889)(4)PreliminaryresultsofaprospectiverandomizedtrialcomparingconcurrentchemoradiotherapyplusadjuvantchemotherapywithradiotherapyaloneinpatientswithlocoregionallyadvancednasopharyngealcarcinomainendemicregionsofChina.InternationalJournalofRadiationOncologyBiologyPhysics.(IF=4.258)(5)Overexpressionofchromosome14openreadingframe166correlateswithdiseaseprogressionandpoorerprognosisinhumanNPC.TumorBiology.(IF=3.611)(6)Ismaximumprimarytumordiameterstillaprognosticfactorinpatientswithnasopharyngealcarcinomatreatedusingintensity-modulatedradiotherapy?BMCCancer.(IF=3.362)(7)Prognosticsignificanceofmaximumprimarytumordiameterinnasopharyngealcarcinoma.BMCCancer.(IF=3.362)(8)Primarytumorregressionspeedafterradiotherapyanditsprognosticsignificanceinnasopharyngealcarcinoma:aretrospectivestudy.BMCCancer.(IF=3.362)(9)Usingthelymphnodalratiotopredicttheriskoflocoregionalrecurrenceinlymphnode-positivebreastcancerpatientstreatedwithmastectomywithoutradiationtherapy.RadiationOncology.(IF=2.546)(10)Spreadingpatterns,prognosticfactorsandtreatmentoutcomesofnasopharyngealpapillaryadenocarcinomaandsalivarygland-typecarcinomas.ClinicalOtolaryngology.(IF=2.113)